Author
1. Gupta Amit
2. Sinha Anirban
3. Jaggi Shalini
4. Bhattacharjee Bikash
ISBN
9789354657740
DOI
10.5005/jp/books/18679_4
Edition
1/e
Publishing Year
2022
Pages
9
Author Affiliations
1.
Center for Diabetes and Allied Sciences, Gurugram, Haryana, India,
Division of Trauma Surgery and Critical Care, Jai Prakash Narayan Apex Trauma Center (JPNATC), All India Institute of Medical Sciences, New Delhi, India,
Promhex Multispeciality Hospital, Greater Noida, Uttar Pradesh, India,
Centre for Diabetes Care, Greater Noida, Uttar Pradesh, India,
Divine Cosmetic Surgery, New Delhi, India,
Medlink Healthcare, Patiala, Punjab, India,
Greater Noida, Uttar Pradesh, India,
JPN Apex Trauma Center, All India Institute of Medical Sciences, New Delhi, India
2.
Medical College Kolkata, Kolkata, West Bengal, India,
Institute of Post Graduate Medical Education and Research (IPGMEAR), Kolkata, West Bengal, India,
Medical College, Kolkata, West Bengal, India
3.
Dr Mohans’ Diabetes Specialities Centre, New Delhi, India,
Dr Mohan’s Diabetes Specialities Center, New Delhi, India,
Dr Mohan Diabetes Specialities Centre, New Delhi, India,
Lifecare Diabetes Centre, Kirti Nagar, New Delhi, India,
Lifecare Diabetes Centre, New Delhi, India,
Dr Mohans’ Diabetes Specialities, Center, New Delhi, India,
Dr Mohans’ Diabetes Specialities Center, New Delhi, India,
Dr Mohans’ Diabetes Specialities Center, New Delhi, India,
Dr Mohans' Diabetes Specialties Centre, New Delhi, India,
Dr Mohan’s Diabetes Specialities Centre, New Delhi, India,
Dr Mohans' Diabetes Specialities Center, New Delhi, India,
Dr Mohans' Diabetes Specialities Centre, New Delhi, India
4.
Sun Valley Diabetes Care and Research Centre, Guwahati, Assam, India,
Sun Valley Diabetic Care and Research Centre, Guwahati, Assam, India
Chapter keywords
Diabetes,
comorbidity,
type 2 diabetes,
postpancreatitis diabetes,
pancreatic cancer,
heart failure,
cardiovascular outcomes trial,
renin-angiotensin system inhibitor,
lower-respiratory tract infection,
pancreatic iron with glucose metabolism,
cardiac complication,
intensive insulin,
intensive metformin,
antidiabetes agents,
rapid exocrine pancreatic dysfunction,
nonalcoholic fatty liver disease,
depression effect,
diabetes investigation
